Showing results (1661-1670 of 2,109) with videos related to

Sort By:
Pageof 211
Cancer Medicine|November 29, 2016
GPX3 methylation in bone marrow predicts adverse prognosis and leukemia transformation in myelodysplastic syndromeJing-Dong Zhou, Jiang Lin, Ting-Juan Zhang, et al.
Journal of Human Hypertension|March 9, 2019
ALDH2 rs671 polymorphism and the risk of heart failure with preserved ejection fraction (HFpEF) in patients with cardiovascular diseasesChun-Lei Xia, Peng Chu, Yi-Xian Liu, et al.
Iscience|January 19, 2026
Autoimmune HLA alleles and neoantigens predict myelodysplastic syndrome outcomes after allogeneic HSCT: A CIBMTR analysisTimothy Sears, Razelle Kurzrock, Tao Zhang, et al.
TAG. Theoretical and Applied Genetics. Theoretische Und Angewandte Genetik|November 3, 2021
Incomplete genome doubling enables to consistently enhance plant growth for maximum biomass production by altering multiple transcript co-expression networks in potatoKanglu Zhao, Nengzhou Jin, Meysam Madadi, et al.
American Journal of Cancer Research|August 14, 2015
GPX3 hypermethylation serves as an independent prognostic biomarker in non-M3 acute myeloid leukemiaJing-Dong Zhou, Dong-Ming Yao, Ying-Ying Zhang, et al.
Oncotargets and Therapy|August 10, 2017
Hypermethylation of secreted frizzled-related proteins predicts poor prognosis in non-M3 acute myeloid leukemiaHong Guo, Ting-Juan Zhang, Xiang-Mei Wen, et al.
Carcinogenesis|February 3, 2012
Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controlsZhibin Hu, Jing Dong, Li-E Wang, et al.
Cancers|December 17, 2024
Correction: Avena et al. 27-Hydroxycholesterol Binds GPER and Induces Progression of Estrogen Receptor-Negative Breast Cancer. Cancers 2022, 14, 1521Paola Avena, Ivan Casaburi, Lucia Zavaglia, et al.
Scientific Reports|January 25, 2024
Identification of gene signatures and molecular mechanisms underlying the mutual exclusion between psoriasis and leprosyYou-Wang Lu, Rong-Jing Dong, Lu-Hui Yang, et al.
Chinese Medicine|May 20, 2023
Traditional Chinese medicine in the era of immune checkpoint inhibitor: theory, development, and future directionsYi-Xuan Yu, Shuo Wang, Zhe-Ning Liu, et al.
Pageof 211